Current Report Filing (8-k)
31 October 2022 - 9:05PM
Edgar (US Regulatory)
0001410428
false
0001410428
2022-10-28
2022-10-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(D) of the Securities
Exchange Act Of 1934
Date of report (Date of earliest event reported):
October 28, 2022
XWELL, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-34785 |
|
20-4988129 |
(Commission File Number) |
|
(IRS Employer Identification No.) |
254
West 31st Street, 11th
Floor, New
York, New
York |
|
10001 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(212) 750-9595
(Registrant’s Telephone Number, Including
Area Code)
XpresSpa Group, Inc.
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $0.01 per share |
|
XWEL |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
October 28, 2022, XWELL, Inc. (the “Company”) received a written notification (the “Notice”) from the Listing
Qualifications Department of the NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price for its
common stock had been below $1.00 for 30 consecutive business days and that the Company therefore is not in compliance with the minimum
bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price
Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock, which continues
to trade on the Nasdaq Capital Market under the symbol “XWEL”.
Under
the Nasdaq Listing Rules, the Company has a period of 180 calendar days from the date of the Notice to regain compliance with the Bid
Price Requirement. Accordingly, the Company has until April 26, 2023 (the “Compliance Date”), to regain compliance
with the Bid Price Requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00
for a minimum of ten consecutive business days prior to the Compliance Date. In the event the Company does not regain compliance by the
Compliance Date, the Company may be eligible for an additional 180 calendar day compliance period. To qualify for this second compliance
period, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other
initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Requirement, and will need to provide written
notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary.
The Company intends to monitor the closing bid
price of its common stock and may, if appropriate, consider available options to regain compliance with the Bid Price Requirement. However,
there can be no assurance that the Company will be able to regain compliance with the Bid Price Requirement, or will otherwise be in compliance
with other Nasdaq Listing Rules.
FORWARD-LOOKING STATEMENTS
This Form
8-K contains forward-looking statements that we intend to be subject to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. All statements contained in this Form 8-K, other than statements of historical facts may constitute forward-looking
statements within the meaning of the federal securities laws. These statements can be identified by words such as “expects,”
“plans,” “projects,” “will,” “may,” “anticipates,” “believes,”
“should,” “intends,” “estimates,” and other words of similar meaning. Any forward-looking statements
contained herein are based on current expectations, and are subject to a number of risks and uncertainties. Many factors could cause our
actual activities or results to differ materially from the activities, performance, achievements or results to differ materially from
the activities and results anticipated in forward-looking statements. These risks and uncertainties include those described in the “Risk
Factors” section as detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission
(“SEC”), including the Company’s annual report on Form 10-K, periodic quarterly reports on Form 10-Q, current reports
on Form 8-K and other documents filed with the SEC. In addition, forward-looking statements may also be adversely affected by general
market factors, general economic and business conditions, including potential adverse effects of public health issues, such as any ongoing
effects of the COVID-19 pandemic (including any new variant strains of the underlying virus) on economic activity, among other factors.
The forward-looking statements contained in this Form 8-K speak only as of the date the statements were made, and the Company does not
undertake any obligation to update forward-looking statements, except as required by law.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
XWELL, Inc. |
|
|
|
Date: October 31,
2022 |
By: |
/s/ Cara
Soffer |
|
Name: |
Cara Soffer |
|
Title: |
General Counsel |
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Sep 2024 to Oct 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about XpresSpa Group Inc (NASDAQ): 0 recent articles
More Xwell, Inc. News Articles